These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 23608073)
1. Dynamic observation of 18F-FDG uptake after oral administration in a healthy subject. Zhang K; Wang X; Hao L; Zhao Z; Han C J Nucl Med Technol; 2013 Jun; 41(2):78-80. PubMed ID: 23608073 [TBL] [Abstract][Full Text] [Related]
2. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396 [TBL] [Abstract][Full Text] [Related]
3. Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy. Aukema TS; Vogel WV; Hoefnagel CA; Valdés Olmos RA J Nucl Med Technol; 2010 Mar; 38(1):24-7. PubMed ID: 20159933 [TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965 [TBL] [Abstract][Full Text] [Related]
5. Investigation of 18F-FDG 3D mode PET image quality versus acquisition time. Brown C; Dempsey MF; Gillen G; Elliott AT Nucl Med Commun; 2010 Mar; 31(3):254-9. PubMed ID: 20032801 [TBL] [Abstract][Full Text] [Related]
6. Human Radiation Dosimetry for Orally and Intravenously Administered Srinivasan S; Crandall JP; Gajwani P; Sgouros G; Mena E; Lodge MA; Wahl RL J Nucl Med; 2020 Apr; 61(4):613-619. PubMed ID: 31628217 [TBL] [Abstract][Full Text] [Related]
7. Substitution of oral (18)F-FDG for intravenous (18)F-FDG in PET scanning. Nair N; Agrawal A; Jaiswar R J Nucl Med Technol; 2007 Jun; 35(2):100-4. PubMed ID: 17496005 [TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. Kang WJ; Kang HJ; Kim HS; Chung JK; Lee MC; Lee DS J Nucl Med; 2006 Aug; 47(8):1295-301. PubMed ID: 16883008 [TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests. Ouyang L; Shi ZY; Lin ZG Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. Jackson RS; Schlarman TC; Hubble WL; Osman MM J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966 [TBL] [Abstract][Full Text] [Related]
11. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin. Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438 [TBL] [Abstract][Full Text] [Related]
12. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439 [TBL] [Abstract][Full Text] [Related]
13. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats. Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002 [TBL] [Abstract][Full Text] [Related]
14. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow. Mullani NA; Herbst RS; O'Neil RG; Gould KL; Barron BJ; Abbruzzese JL J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436 [TBL] [Abstract][Full Text] [Related]
15. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging. Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223 [TBL] [Abstract][Full Text] [Related]
16. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431 [TBL] [Abstract][Full Text] [Related]
17. The impact of different 18FDG PET healthy subject scans for comparison with single patient in SPM analysis. Gallivanone F; Della Rosa PA; Perani D; Gilardi MC; Castiglioni I; Q J Nucl Med Mol Imaging; 2017 Mar; 61(1):115-132. PubMed ID: 25479418 [TBL] [Abstract][Full Text] [Related]
18. Finding the sweet spot for metformin in 18F-FDG-PET. Morris M; Saboury B; Chen W; Siegel EL; Dasgeb B Nucl Med Commun; 2017 Oct; 38(10):875-880. PubMed ID: 28800002 [TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of heat-denatured [ Matsusaka Y; Nakahara T; Takahashi K; Iwabuchi Y; Ogata Y; Nishime C; Kajimura M; Jinzaki M Nucl Med Biol; 2018 Jan; 56():26-30. PubMed ID: 29125999 [TBL] [Abstract][Full Text] [Related]
20. The effects of hypotonic and isotonic negative contrast agent on gastrointestinal distention and physiological intake of 18F-FDG. Zhang L; Liang ML; Zhang YK; Hu SS; Chen L; Li HT; Wang J Nucl Med Commun; 2015 Feb; 36(2):180-6. PubMed ID: 25321162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]